Skip to main content

iksa began as an AI lab inside the leading regenerative medicine provider in East Asia

Iksa is short for “ikshana”, which means to provide care with the utmost sight. We build for the doctors who practice that way.

The group’s CEO and COO, on film · 2:38Watch the case study

Why we started

We came to this medicine from clinical trials, and what stayed with us was everything a trial builds around one protocol: the schedule, the monitoring, the watch for side effects, every change kept with its reason. Then we met doctors running protocols every bit as demanding for one patient at a time, and holding all of that together themselves.

So we went to work beside them. We built iksa inside a group where a plan is written for one person and carried out over years, and where the same clinic often cares for several generations of one family. The group’s doctors and nurses were in the room with us. We started with patients already in care, and then the nurses who carry their protocols every day.

How we work

The doctor decides.
We build for the person carrying the patient, and we’ve turned down work that would have put AI between pharma, doctors and patients.
We learn in the room.
We ask a clinic for its hardest patient, because that’s where we find out what we got wrong.
We hold our words to the evidence.
Nothing we ship reaches a clinic until it has passed its evals, and we say what the evidence shows and stop there.
We’re in this for years.
The patients we build for stay for years, and the people who advise us go back as far as fifteen years with us.

We go back over a decade across life sciences, enterprise software and healthcare

Our team and advisors have formed the platform with their depth and commitment.

  • Clinical and personalized medicine

    We’ve cared for patients and studied how treatment fits the person.

    • Johns Hopkins University
    • Intermountain Health
    • Harvard University
  • Drug development and clinical trials

    We’ve designed trials, run them and seen therapies through them to patients.

    • Novartis
    • Novo Nordisk
    • Cytel
  • Life-sciences commercial and operations

    We’ve planned, priced and launched therapies for the largest drug companies.

    • McKinsey & Company
    • GSK
    • Pfizer
  • Data, AI and software at scale

    We’ve built the data systems that clinical trials and genetic testing run on.

    • Medidata
    • Myriad Genetics
    • Massachusetts Institute of Technology

Talk to the team that builds the harness for n‑of‑1 medicine

Bring a protocol you run. We’ll walk one patient through it.